|4Apr 2, 7:02 PM ET

BOYER HERBERT W PH D 4

4 · ALLERGAN INC · Filed Apr 2, 2013

Insider Transaction Report

Form 4
Period: 2013-04-01
Transactions
  • Award

    Phantom Stock Units

    2013-03-21$110.42/sh+8.13$89817,954.76 total
    Common Stock (8.13 underlying)
  • Award

    Phantom Stock Units

    2013-04-01$112.58/sh+222.06$25,00018,176.82 total
    Common Stock (222.06 underlying)
Footnotes (4)
  • [F1]Converts to common stock on a 1-for-1 basis.
  • [F2]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for quarterly dividend, exempt transaction under Rule 16a-11.
  • [F3]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. Director.
  • [F4]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for quarterly portion of annual retainer.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT